Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension
- PMID: 1974501
- DOI: 10.1007/BF01409479
Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension
Abstract
We studied the effects of oral carvedilol (20 mg/day) on cerebral blood flow (CBF) and CBF autoregulation in ten previous stroke patients with hypertension. Measurement of CBF was done by the argon inhalation method. CBF autoregulation was also studied by the (A-V)O2 method after stepwise reduction in systemic blood pressure. After 1 week of carvedilol administration, the mean arterial blood pressure showed an 18% decrease, with no significant changes in CBF, CBF autoregulation, or other cerebral circulation parameters. From these findings, it can be said that carvedilol is a potent antihypertensive agent that does not affect cerebral circulation parameters.
Similar articles
-
Blood pressure lowering and cerebral blood flow: a comparison of the effects of carvedilol and propranolol on the cerebral circulation in hypertensive patients.J Cardiovasc Pharmacol. 1992;19 Suppl 1:S40-3. J Cardiovasc Pharmacol. 1992. PMID: 1378148 Clinical Trial.
-
Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.Eur J Clin Pharmacol. 1990;38 Suppl 2:S115-9. doi: 10.1007/BF01409478. Eur J Clin Pharmacol. 1990. PMID: 1974500
-
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.J Cardiovasc Pharmacol. 1987;10 Suppl 11:S94-6. J Cardiovasc Pharmacol. 1987. PMID: 2454377
-
Hemodynamic profile of carvedilol.Eur J Clin Pharmacol. 1990;38 Suppl 2:S101-3. doi: 10.1007/BF01409474. Eur J Clin Pharmacol. 1990. PMID: 1974496 Review.
-
Vasodilatory action of carvedilol.J Cardiovasc Pharmacol. 1992;19 Suppl 1:S5-11. doi: 10.1097/00005344-199219001-00003. J Cardiovasc Pharmacol. 1992. PMID: 1378150 Review.
Cited by
-
Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1993 Feb;45(2):232-58. doi: 10.2165/00003495-199345020-00006. Drugs. 1993. PMID: 7681374 Review.
-
Clinical pharmacokinetics and pharmacodynamics of carvedilol.Clin Pharmacokinet. 1994 May;26(5):335-46. doi: 10.2165/00003088-199426050-00002. Clin Pharmacokinet. 1994. PMID: 7914479 Review.
-
Long-term hemodynamic effects of antihypertensive treatment.Clin Investig. 1992;70 Suppl 1:S58-64. doi: 10.1007/BF00207613. Clin Investig. 1992. PMID: 1350486
-
Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.Drugs. 1997 Jul;54(1):161-85. doi: 10.2165/00003495-199754010-00015. Drugs. 1997. PMID: 9211087 Review.
-
Clinical pharmacology of carvedilol.Clin Investig. 1992;70 Suppl 1:S27-36. doi: 10.1007/BF00207608. Clin Investig. 1992. PMID: 1350481 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical